Stock UniverseDerived research view · source repositories remain read-only

Genmab A/S (GMAB)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
High
Selection Score
41.92
Global Rank
239
Market Cap
18.00B
Latest Close
25.15
RS Composite
-20.04% · G#2645

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-9.82%
3M
-7.06%
6M
-20.61%
1Y
15.47%
3Y
-35.86%
5Y
-38.08%
10Y
39.45%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 2.08M · 30-day average: 2.04M · Max drawdown over stored range: -63.10%

Research Snapshot

Relative Strength vs SPX

RS Composite-20.04%
20D RS-7.69%
60D RS-17.12%
120D RS-29.13%
Global RS Rank2645 · 21.16% percentile
Qualified+ RS Rank1021 · 18.84% percentile
Group ScopeQualified+
Primary RS Rank295 · 35.59% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank16 / 701
Primary Percentile97.86
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for GMAB.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue1287.43422084.0547239031213720
Revenue Growth (YoY)-22.521%61.877%14.68%30.586%19.193%
Gross Profit1287.43422084.0547235729783482
Operating Income451.6803900.432377210151250
Free Cash Flow302.2419516.5237101810991149
Free Cash Flow Per Share4.5767.82515.44816.99818.328
EPS (Diluted) GAAP6.84785911.8663969.5817.5315.369999
EPS Growth-42.296%73.286%-19.268%82.985%-12.322%
EPS Non-GAAP
Gross Margin100%100%98.619%95.418%93.602%
Operating Margin35.084%43.206%32.301%32.522%33.602%
Profit Margin35.131%37.587%26.402%36.302%25.887%
Free Cash Flow Margin23.476%24.785%42.594%35.213%30.887%
Shares Outstanding (Diluted)66.045866.009665.897664.65662.6916
Shares Change (YoY)0.243%-0.055%-0.17%-1.884%-3.038%

SEC Quarterly Fundamentals

No processed quarterly rows for GMAB.